ISAIAH WILES: Open Payments
NPI 1548974843 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,304 in 59 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $654 · 2025 $1,304
Food & beverage: $1,284Education: $20
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $210 |
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| Legend Biotech USA Inc. | 6 | $132 |
| ABBVIE INC. | 6 | $128 |
| Genmab U.S., Inc. | 4 | $91 |
| GENZYME CORPORATION | 4 | $86 |
| Syndax Pharmaceuticals, Inc. | 3 | $68 |
| Rigel Pharmaceuticals, Inc. | 3 | $64 |
| Genentech USA, Inc. | 2 | $56 |
| SANOFI-AVENTIS U.S. LLC | 2 | $45 |
Products named: CARVYKTI, Epkinly, NIKTIMVO, VENCLEXTA, JAKAFI, SARCLISA, Fabhalta, SCEMBLIX.
Industry payments across KY — which companies pay providers there.
